Sponsored by the HealthcareTrainingInstitute.org providing Quality Education since 1979
Home > CEU courses > HIV/AIDS > HIV: Therapeutic Strategies for Guilt, Uncertainty, and Taking Control > State HIV Prevention Progress Report 2014Add to Shopping Cart

HIV: Therapeutic Strategies for Guilt, Uncertainty, and Taking Control
6 CEUs Cultural Diversity & Ethical Boundaries: Freedom from Stereotypes

Section 18
State HIV Prevention Progress Report 2014

CEU Test | Table of Contents | HIV/AIDS CEU Courses
Counselor CEUs, Social Worker CEUs, Psychologist CEs, MFT CEUs 


The Flip Book below is from Centers for Disease Control and Prevention 

Hint:
1. Use + and – at top of page to increase or decrease size
2. Click and drag on page to move text to be more visible , if needed
3. Click speaker at top of page to add or delete sound
4. If message below indicates "A plugin is needed to display this content." CLICK HERE
Questions? Email: [email protected]

- Dietz, Patricia M. ,DrPH, Amy L. Krueger, MPH, Richard J. Wolitski, PhD, Anna Satcher Johnson, MPH, Erica Dunbar, MPH, Lillian S. Lin, PhD, Samuel Dooley, MD, Donna Hubbard McCree, PhD, Shubha Rao, MPH, H. Irene Hall, PhD Dale Stratford, PhD, State HIV Prevention Progress Report 2014, Centers for Disease Control and Prevention 2014, p1-108.


  
Others who bought this HIV/AIDS Course
also bought…
Scroll Down
Scroll UpCourse Listing Bottom Cap

CEU Test for this course | HIV/AIDS CEU Courses
Forward to Section 19
Back to Section 17
Table of Contents
Top

The article above contains foundational information. Articles below contain optional updates.
Positive and motivational messages, not a focus on risk, needed for PrEP communications in South Africa
Young women in South Africa prefer demand-creation materials for PrEP that are empowering and motivational, according to a report from a project in a township near Cape Town, published in Gates Open Research. The multiple rounds of consultation with community members resulted in materials that did not focus on risk, prevention or even health. Instead, the campaign video emphasised young people’s control over their lives and being part of a generation that will end HIV.
Injectable antiretrovirals for HIV treatment or prevention: ambivalent views of potential users
“Coming to the hospital every month, with people who work from 9:00 am to 5:00 pm…Waiting in line because they [medical team] are late, because there’s something which doesn’t work. When you are working, it’s just unmanageable. If it’s only once or twice a year, nobody sees anything, but if it’s every month, you arrive late at your office… It makes you too uncomfortable.” Isabelle, diagnosed with HIV in 1984. “I would dream of a week without any drugs”. Pierre, diagnosed with HIV in 1988.
Black people and women are under represented in anti-HIV drug studies
Recruitment to clinical trials that lead to the licensing of antiretroviral drugs is not representative of the global HIV pandemic, an international group of researchers report in the Journal of Virus Eradication.  Licensing studies were overwhelming conducted in richer countries and white men were massively over-recruited. Failure to recruit a representative population could mean that important information about the pharmacokinetics of drugs is missed and that potentially dangerous side effects go unnoticed in this key stage in the drug approval process.
Depression adversely affects cognitive function of people with HIV in both the short- and longer-term
Sustained depression is associated with long-term declines in cognitive function among people living with HIV, investigators from the United States report in the Journal of Acquired Immune Deficiency Syndromes. Executive functioning, recall and verbal fluency were all adversely affected by long-term depression. The study also showed that acute depression also had an impact on key aspects of cognitive function, including motor skills and speed of thought.
'I stopped PrEP and caught HIV': US researchers ask why
Individuals who stop PrEP may still remain at high risk of infection with HIV, according to research conducted in San Francisco and published in the Journal of the International AIDS Society. In-depth interviews with individuals who seroconverted to HIV after taking PrEP showed that major obstacles to remaining on it included drug use, mental health problems, housing insecurity, difficulty access the medication (expense, cost and time required for medical appointments), difficulty weighing up the risk and benefits of PrEP, and entering a committed relationship.

CEU Continuing Education for
Social Work CEUs, Psychology CEUs, Counselor CEUs, MFT CEUs

 

OnlineCEUcredit.com Login


Forget your Password Reset it!